Literature DB >> 32154799

Is perfusate exchange during ex vivo lung perfusion beneficial?

Christina C Kao1, Amit D Parulekar1.   

Abstract

Entities:  

Year:  2020        PMID： 32154799      PMCID： PMC7036634          DOI： 10.21037/atm.2019.12.127

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

1.  Kinetics of lactate metabolism during acellular normothermic ex vivo lung perfusion.

Authors:  Terumoto Koike; Jonathan C Yeung; Marcelo Cypel; Matthew Rubacha; Yasushi Matsuda; Masaaki Sato; Thomas K Waddell; Mingyao Liu; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2011-09-17       Impact factor: 10.247

2.  Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.

Authors:  Simon Becker; Jasmin Steinmeyer; Murat Avsar; Klaus Höffler; Jawad Salman; Axel Haverich; Gregor Warnecke; Matthias Ochs; Anke Schnapper
Journal:  Transpl Int       Date:  2015-08-27       Impact factor: 3.782

3.  OPTN/SRTR 2017 Annual Data Report: Lung.

Authors:  M Valapour; C J Lehr; M A Skeans; J M Smith; K Uccellini; R Lehman; A Robinson; A K Israni; J J Snyder; B L Kasiske
Journal:  Am J Transplant       Date:  2019-02       Impact factor: 8.086

4.  Pushing the limits of reconditioning: extended normothermic lung perfusion in an extended criteria donor.

Authors:  Marco Schiavon; Davide Zampieri; Giuseppe Marulli; Enrico Verderi; Alessandro Rebusso; Giovanni Maria Comacchio; Samuele Nicotra; Monica Loy; Francesca Lunardi; Paolo Feltracco; Fiorella Calabrese; Emanuele Cozzi; Federico Rea
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 5.  Ex Vivo Lung Perfusion: A Key Tool for Translational Science in the Lungs.

Authors:  Shinya Tane; Kentaro Noda; Norihisa Shigemura
Journal:  Chest       Date:  2017-02-24       Impact factor: 9.410

6.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation.

Authors:  Daniel C Chambers; Wida S Cherikh; Samuel B Goldfarb; Don Hayes; Anna Y Kucheryavaya; Alice E Toll; Kiran K Khush; Bronwyn J Levvey; Bruno Meiser; Joseph W Rossano; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2018-08-11       Impact factor: 10.247

7.  Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates.

Authors:  Gabriel Loor; Brian T Howard; John R Spratt; Lars M Mattison; Angela Panoskaltsis-Mortari; Roland Z Brown; Tinen L Iles; Carolyn M Meyer; Haylie R Helms; Andrew Price; Paul A Iaizzo
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

8.  Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion.

Authors:  Miral R Sadaria; Phillip D Smith; David A Fullerton; George A Justison; Joon H Lee; Ferenc Puskas; Frederick L Grover; Joseph C Cleveland; T Brett Reece; Michael J Weyant
Journal:  Ann Thorac Surg       Date:  2011-06-25       Impact factor: 4.330

9.  Technique for prolonged normothermic ex vivo lung perfusion.

Authors:  Marcelo Cypel; Jonathan C Yeung; Shin Hirayama; Matthew Rubacha; Stefan Fischer; Masaki Anraku; Masaaki Sato; Stephen Harwood; Andrew Pierre; Thomas K Waddell; Marc de Perrot; Mingyao Liu; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

10.  Regeneration of severely damaged lungs using an interventional cross-circulation platform.

Authors:  Brandon A Guenthart; John D O'Neill; Jinho Kim; Dawn Queen; Scott Chicotka; Kenmond Fung; Michael Simpson; Rachel Donocoff; Michael Salna; Charles C Marboe; Katherine Cunningham; Susan P Halligan; Holly M Wobma; Ahmed E Hozain; Alexander Romanov; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  Nat Commun       Date:  2019-05-07       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.